France In Vitro Diagnostics Market Outlook to 2016SummaryGlobalData's new report, 'France In Vitro Diagnostics Market Outlook to 2016' provides key market data on the France In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories ' clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Scope- Market size and company share data for In Vitro Diagnostics (IVD) market categories ' clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. - 2009 company shares and distribution shares data for each of the seven market categories.- Global corporate-level profiles of key companies operating within the France In Vitro Diagnostics (IVD) market.- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.Reasons to buy- Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the France In Vitro Diagnostics (IVD) competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution ' Identify, understand and capitalize.
RAFAEL CABRERA P. Poster porto petit 2 contactoRafael Cabrera
El documento presenta indicadores socioeconómicos del departamento de Tolima, Colombia, que muestran un rezago científico-tecnológico y bajo desarrollo a pesar de sus ventajas. Se describe la metodología utilizada para formular un Plan Estratégico de Ciencia, Tecnología e Innovación para la región, incluyendo diagnóstico, formulación, delimitación de áreas de acción y resultados. El plan propone programas y proyectos para fortalecer la institucionalidad, desarrollar soluciones innovador
Tekst die hoort bij de slides van de inleiding van Han Nichting voor het congres Trends voor Trainers, 14 januari 2011. http://www.trendsvoortrainers.nl
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
RAFAEL CABRERA P. Poster porto petit 2 contactoRafael Cabrera
El documento presenta indicadores socioeconómicos del departamento de Tolima, Colombia, que muestran un rezago científico-tecnológico y bajo desarrollo a pesar de sus ventajas. Se describe la metodología utilizada para formular un Plan Estratégico de Ciencia, Tecnología e Innovación para la región, incluyendo diagnóstico, formulación, delimitación de áreas de acción y resultados. El plan propone programas y proyectos para fortalecer la institucionalidad, desarrollar soluciones innovador
Tekst die hoort bij de slides van de inleiding van Han Nichting voor het congres Trends voor Trainers, 14 januari 2011. http://www.trendsvoortrainers.nl
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
This document provides a summary and table of contents of the "World Biomass Report" published in November 2012. The report examines the global biomass market and finds that while it suffered during the economic downturn due to low coal prices and supply issues, the sector began growing again in 2010 as coal prices rose. Most biomass plants rely on wood pellets imported from North America, though suppliers from other regions like Russia and Australia aim to compete in the market. The full report contains detailed information on biomass resources, technologies, logistics, investments and policies on a global and national level.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
This document provides a summary and table of contents of the "World Biomass Report" published in November 2012. The report examines the global biomass market and finds that while it suffered during the economic downturn due to low coal prices and supply issues, the sector began growing again in 2010 as coal prices rose. Most biomass plants rely on wood pellets imported from North America, though suppliers from other regions like Russia and Australia aim to compete in the market. The full report contains detailed information on biomass resources, technologies, logistics, investments and policies on a global and national level.
France In Vitro Diagnostics Market Outlook to 2016
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
France In Vitro Diagnostics Market Outlook to 2016
Published on June 2010
Report Summary
France In Vitro Diagnostics Market Outlook to 2016
Summary
GlobalData's new report, 'France In Vitro Diagnostics Market Outlook to 2016' provides key market data on the France In Vitro
Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment
and sub-segment within seven market categories ' clinical chemistry, genetic testing, histology and cytology, immuno chemistry,
infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data
for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market
participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics (IVD) market categories ' clinical chemistry, genetic testing, histology
and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and
sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the France In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and
Becton, Dickinson.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution ' Identify, understand and
capitalize.
Table of Content
1 Table of Contents 2
1.1 List of Tables 8
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 1/11
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About' 14
3 In Vitro Diagnostics In France 15
3.1 In Vitro Diagnostics, Market Segmentation 15
3.2 In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 16
3.3 In Vitro Diagnostics Market, France, Revenue Mix ($m), 2009 18
3.4 In Vitro Diagnostics Market, France, Category Contribution (%), 2009 19
3.5 In Vitro Diagnostics, France, Company Share (2008-2009) 25
4 Clinical Chemistry In France 27
4.1 Clinical Chemistry, Market Segmentation 27
4.2 Clinical Chemistry Market, France, Revenue Mix ($m), 2009 28
4.3 Clinical Chemistry Market, France, Category Contribution (%), 2009 29
4.4 Clinical Chemistry Overall Revenue (2002-2016) 30
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 34
4.4.2 Urine Analysis Revenue (2002-2016) 38
4.5 Clinical Chemistry Distribution Share (2008-2009) 42
4.6 Clinical Chemistry, France, Company Share (2008-2009) 43
5 Genetic Testing In France 45
5.1 Genetic Testing, Market Segmentation 45
5.2 Genetic Testing Market, France, Revenue Mix ($m), 2009 46
5.3 Genetic Testing Market, France, Category Contribution (%), 2009 47
5.4 Genetic Testing Overall Revenue (2002-2016) 48
5.5 Genetic Testing Distribution Share (2008-2009) 52
5.6 Genetic Testing, France, Company Share (2008-2009) 53
6 Haematology In France 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, France, Revenue Mix ($m), 2009 56
6.3 Haematology Market, France, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 70
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74
6.4.5 Haematology Cell Counters Revenue (2002-2016) 78
6.5 Haematology Distribution Share (2008-2009) 82
6.6 Haematology, France, Company Share (2008-2009) 83
7 Histology And Cytology In France 85
7.1 Histology And Cytology, Market Segmentation 85
7.2 Histology And Cytology Market, France, Revenue Mix ($m), 2009 86
7.3 Histology And Cytology Market, France, Category Contribution (%), 2009 87
7.4 Histology And Cytology Overall Revenue (2002-2016) 88
7.4.1 Histology Revenue (2002-2016) 92
7.5 Histology And Cytology Distribution Share (2008-2009) 96
7.6 Histology And Cytology, France, Company Share (2008-2009) 97
8 Immuno Chemistry In France 99
8.1 Immuno Chemistry, Market Segmentation 99
8.2 Immuno Chemistry Market, France, Revenue Mix ($m), 2009 100
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 2/11
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
8.3 Immuno Chemistry Market, France, Category Contribution (%), 2009 101
8.4 Immuno Chemistry Overall Revenue (2002-2016) 102
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 106
8.4.2 Drug Related Testing Revenue (2002-2016) 110
8.4.3 Endocrinology Tests Revenue (2002-2016) 114
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 118
8.5 Immuno Chemistry Distribution Share (2008-2009) 122
8.6 Immuno Chemistry, France, Company Share (2008-2009) 123
9 Infectious Immunology In France 125
9.1 Infectious Immunology, Market Segmentation 125
9.2 Infectious Immunology Market, France, Revenue Mix ($m), 2009 126
9.3 Infectious Immunology Market, France, Category Contribution (%), 2009 127
9.4 Infectious Immunology Overall Revenue (2002-2016) 128
9.5 Infectious Immunology Distribution Share (2008-2009) 132
9.6 Infectious Immunology, France, Company Share (2008-2009) 133
10 Microbiology Culture In France 135
10.1 Microbiology Culture, Market Segmentation 135
10.2 Microbiology Culture Market, France, Revenue Mix ($m), 2009 136
10.3 Microbiology Culture Market, France, Category Contribution (%), 2009 137
10.4 Microbiology Culture Overall Revenue (2002-2016) 138
10.4.1 Microbiology Analyzers Revenue (2002-2016) 142
10.5 Microbiology Culture Distribution Share (2008-2009) 146
10.6 Microbiology Culture, France, Company Share (2008-2009) 147
11 Overview of Key Companies in France In Vitro Diagnostics Market 149
11.1 F. Hoffmann-La Roche Ltd. 149
11.1.1 Company Overview 149
11.1.2 Share in the France In Vitro Diagnostics Market 149
11.2 Siemens Healthcare 150
11.2.1 Company Overview 150
11.2.2 Share in the France In Vitro Diagnostics Market 150
11.3 Abbott Laboratories 151
11.3.1 Company Overview 151
11.3.2 Share in the France In Vitro Diagnostics Market 151
11.4 bioMerieux S.A. 152
11.4.1 Company Overview 152
11.4.2 Share in the France In Vitro Diagnostics Market 152
11.5 Beckman Coulter, Inc. 153
11.5.1 Company Overview 153
11.5.2 Share in the France In Vitro Diagnostics Market 153
11.6 Ortho-Clinical Diagnostics Inc. 154
11.6.1 Company Overview 154
11.6.2 Share in the France In Vitro Diagnostics Market 154
11.7 Inverness Medical Innovations, Inc. 155
11.7.1 Company Overview 155
11.8 Becton, Dickinson and Company 155
11.8.1 Company Overview 155
11.9 Bio-Rad Laboratories, Inc. 156
11.9.1 Company Overview 156
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 3/11
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
11.10 Hologic, Inc. 156
11.10.1 Company Overview 156
11.11 OLYMPUS CORPORATION 157
11.11.1 Company Overview 157
11.12 Mindray Medical International Limited 157
11.12.1 Company Overview 157
11.13 DiaSorin S.p.A 158
11.13.1 Company Overview 158
11.14 Qiagen N.V. 158
11.14.1 Company Overview 158
11.15 Gen-Probe Incorporated 159
11.15.1 Company Overview 159
11.16 Phadia AB 159
11.16.1 Company Overview 159
11.17 Sysmex Europe GmbH 160
11.17.1 Company Overview 160
11.18 Argene S.A. 160
11.18.1 Company Overview 160
11.19 Biocode Hycel 160
11.19.1 Company Overview 160
11.20 EUROMEDEX 161
11.20.1 Company Overview 161
11.21 The Elitech Group 161
11.21.1 Company Overview 161
12 In Vitro Diagnostics Market Pipeline Products 162
12.1 Clinical Chemisty Market Pipeline Products 162
12.2 Immuno Chemistry Market Pipeline Products 164
12.3 Haematology Market Pipeline Products 166
12.4 Infectious Immunology Market Pipeline Products 167
12.5 Microbiology Culture Market Pipeline Products 169
12.6 Histology and Cytology Market Pipeline Products 170
12.7 Genetic Testing Market Pipeline Products 171
13 Financial Deals Landscape 173
13.1 Partnerships 173
13.1.1 Diamedix Enters Into Distribution Agreement With Fumouze Diagnostics 173
13.1.2 Transgenomic Enters Into Licensing Agreement With IntegraGen 174
13.1.3 QIAGEN Enters Into Distribution Agreement With Celera 175
13.1.4 DiaGenic Enters Into Distribution Agreement With Ferrer inCode 176
13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 177
13.1.6 Royal Philips Electronics Enters Into An Agreement With bioMerieux 178
13.1.7 Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics 179
13.1.8 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 180
14 Recent Developments 181
14.1 Strategy and Business Planning 181
14.1.1 Dec 08, 2009: Genetix Expands Sales, Support And Service Organization In France And Benelux 181
14.2 Product News 181
14.2.1 Jan 11, 2010: Ipsogen and Institut Curie Forms Alliance for MapQuant Dx Grade Genomic HER2 and HR Tests 181
14.2.2 Dec 03, 2009: ExonHit Launches AclarusDx Alzheimer's Test For Research Use 182
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 4/11
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
15 Appendix 183
15.1 Definitions of Markets Covered in the Report 184
15.1.1 In Vitro Diagnostics 184
15.2 Research Methodology 192
15.3 Secondary Research 193
15.4 Primary Research 193
15.5 Models 194
15.6 Forecasts 194
15.7 Expert Panels 194
15.8 GlobalData Consulting 194
15.9 Currency Conversion 195
15.10 Contact Us 195
15.11 Disclaimer 195
1.1 List of Tables
Table 1: In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 17
Table 2: In Vitro Diagnostics Market, France, Category Contribution (%), 2009 19
Table 3: In Vitro Diagnostics, France, Cross-Category Analysis, 2002-2016 20
Table 4: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2002-2009 22
Table 5: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2009-2016 24
Table 6: In Vitro Diagnostics, France, Company Share by Revenue ($m), 2008-2009 26
Table 7: Clinical Chemistry Market, France, Category Contribution (%), 2009 29
Table 8: Clinical Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 31
Table 9: Clinical Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 33
Table 10: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Table 11: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Table 12: Urine Analysis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Table 13: Urine Analysis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Table 14: Clinical Chemistry, France, Distribution Share by Revenue ($m), 2008-2009 42
Table 15: Clinical Chemistry, France, Company Share by Revenue ($m), 2008-2009 44
Table 16: Genetic Testing Market, France, Category Contribution (%), 2009 47
Table 17: Genetic Testing, France, Revenue ($m) by Segment, Historic, 2002-2009 49
Table 18: Genetic Testing, France, Revenue ($m) by Segment, Forecast, 2009-2016 51
Table 19: Genetic Testing, France, Distribution Share by Revenue ($m), 2008-2009 52
Table 20: Genetic Testing, France, Company Share by Revenue ($m), 2008-2009 54
Table 21: Haematology Market, France, Category Contribution (%), 2009 57
Table 22: Haematology, France, Revenue ($m) by Segment, Historic, 2002-2009 59
Table 23: Haematology, France, Revenue ($m) by Segment, Forecast, 2009-2016 61
Table 24: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63
Table 25: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65
Table 26: Immunohaematology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67
Table 27: Immunohaematology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69
Table 28: Haemostasis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71
Table 29: Haemostasis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Table 30: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75
Table 31: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77
Table 32: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79
Table 33: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 5/11
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 34: Haematology, France, Distribution Share by Revenue ($m), 2008-2009 82
Table 35: Haematology, France, Company Share by Revenue ($m), 2008-2009 84
Table 36: Histology And Cytology Market, France, Category Contribution (%), 2009 87
Table 37: Histology And Cytology, France, Revenue ($m) by Segment, Historic, 2002-2009 89
Table 38: Histology And Cytology, France, Revenue ($m) by Segment, Forecast, 2009-2016 91
Table 39: Histology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 93
Table 40: Histology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 95
Table 41: Histology And Cytology, France, Distribution Share by Revenue ($m), 2008-2009 96
Table 42: Histology And Cytology, France, Company Share by Revenue ($m), 2008-2009 98
Table 43: Immuno Chemistry Market, France, Category Contribution (%), 2009 101
Table 44: Immuno Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 103
Table 45: Immuno Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 105
Table 46: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107
Table 47: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109
Table 48: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 111
Table 49: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 113
Table 50: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 115
Table 51: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 117
Table 52: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 119
Table 53: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 121
Table 54: Immuno Chemistry, France, Distribution Share by Revenue ($m), 2008-2009 122
Table 55: Immuno Chemistry, France, Company Share by Revenue ($m), 2008-2009 124
Table 56: Infectious Immunology Market, France, Category Contribution (%), 2009 127
Table 57: Infectious Immunology, France, Revenue ($m) by Segment, Historic, 2002-2009 129
Table 58: Infectious Immunology, France, Revenue ($m) by Segment, Forecast, 2009-2016 131
Table 59: Infectious Immunology, France, Distribution Share by Revenue ($m), 2008-2009 132
Table 60: Infectious Immunology, France, Company Share by Revenue ($m), 2008-2009 134
Table 61: Microbiology Culture Market, France, Category Contribution (%), 2009 137
Table 62: Microbiology Culture, France, Revenue ($m) by Segment, Historic, 2002-2009 139
Table 63: Microbiology Culture, France, Revenue ($m) by Segment, Forecast, 2009-2016 141
Table 64: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 143
Table 65: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 145
Table 66: Microbiology Culture, France, Distribution Share by Revenue ($m), 2008-2009 146
Table 67: Microbiology Culture, France, Company Share by Revenue ($m), 2008-2009 148
Table 68: Clinical Chemisty Market Pipeline Products 162
Table 69: Immuno Chemistry Market Pipeline Products 164
Table 70: Haematology Market Pipeline Products 166
Table 71: Infectious Immunology Market Pipeline Products 167
Table 72: Microbiology Culture Market Pipeline Products 169
Table 73: Histology and Cytology Market Pipeline Products 170
Table 74: Genetic Testing Market Pipeline Products 171
Table 75: Diamedix Enters Into Distribution Agreement With Fumouze Diagnostics 173
Table 76: Transgenomic Enters Into Licensing Agreement With IntegraGen 174
Table 77: QIAGEN Enters Into Distribution Agreement With Celera 175
Table 78: DiaGenic Enters Into Distribution Agreement With Ferrer inCode 176
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 177
Table 80: Royal Philips Electronics Enters Into An Agreement With bioMerieux 178
Table 81: Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics 179
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 6/11
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 82: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 180
Table 83: USD to Local Currency, France, Average Actual Rate 2002-2009 195
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 15
Figure 2: In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 16
Figure 3: In Vitro Diagnostics Market, France, Revenue Mix ($m), 2009 18
Figure 4: In Vitro Diagnostics Market, France, Category Contribution (%), 2009 19
Figure 5: In Vitro Diagnostics, France, Cross-Category Analysis, 2002-2016 20
Figure 6: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2002-2009 21
Figure 7: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2009-2016 23
Figure 8: In Vitro Diagnostics, France, Company Share (%), 2009 25
Figure 9: Clinical Chemistry, Market Segmentation 27
Figure 10: Clinical Chemistry Market, France, Revenue Mix ($m), 2009 28
Figure 11: Clinical Chemistry Market, France, Category Contribution (%), 2009 29
Figure 12: Clinical Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 30
Figure 13: Clinical Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 32
Figure 14: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 34
Figure 15: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36
Figure 16: Urine Analysis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Figure 17: Urine Analysis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Figure 18: Clinical Chemistry, France, Company Share (%), 2009 43
Figure 19: Genetic Testing, Market Segmentation 45
Figure 20: Genetic Testing Market, France, Revenue Mix ($m), 2009 46
Figure 21: Genetic Testing Market, France, Category Contribution (%), 2009 47
Figure 22: Genetic Testing, France, Revenue ($m) by Segment, Historic, 2002-2009 48
Figure 23: Genetic Testing, France, Revenue ($m) by Segment, Forecast, 2009-2016 50
Figure 24: Genetic Testing, France, Company Share (%), 2009 53
Figure 25: Haematology, Market Segmentation 55
Figure 26: Haematology Market, France, Revenue Mix ($m), 2009 56
Figure 27: Haematology Market, France, Category Contribution (%), 2009 57
Figure 28: Haematology, France, Revenue ($m) by Segment, Historic, 2002-2009 58
Figure 29: Haematology, France, Revenue ($m) by Segment, Forecast, 2009-2016 60
Figure 30: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 31: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Figure 32: Immunohaematology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Figure 33: Immunohaematology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Figure 34: Haemostasis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Figure 35: Haemostasis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Figure 36: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Figure 37: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76
Figure 38: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Figure 39: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Figure 40: Haematology, France, Company Share (%), 2009 83
Figure 41: Histology And Cytology, Market Segmentation 85
Figure 42: Histology And Cytology Market, France, Revenue Mix ($m), 2009 86
Figure 43: Histology And Cytology Market, France, Category Contribution (%), 2009 87
Figure 44: Histology And Cytology, France, Revenue ($m) by Segment, Historic, 2002-2009 88
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 7/11
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 45: Histology And Cytology, France, Revenue ($m) by Segment, Forecast, 2009-2016 90
Figure 46: Histology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92
Figure 47: Histology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94
Figure 48: Histology And Cytology, France, Company Share (%), 2009 97
Figure 49: Immuno Chemistry, Market Segmentation 99
Figure 50: Immuno Chemistry Market, France, Revenue Mix ($m), 2009 100
Figure 51: Immuno Chemistry Market, France, Category Contribution (%), 2009 101
Figure 52: Immuno Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 102
Figure 53: Immuno Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 104
Figure 54: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Figure 55: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Figure 56: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 110
Figure 57: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 112
Figure 58: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 114
Figure 59: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 116
Figure 60: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 118
Figure 61: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 120
Figure 62: Immuno Chemistry, France, Company Share (%), 2009 123
Figure 63: Infectious Immunology, Market Segmentation 125
Figure 64: Infectious Immunology Market, France, Revenue Mix ($m), 2009 126
Figure 65: Infectious Immunology Market, France, Category Contribution (%), 2009 127
Figure 66: Infectious Immunology, France, Revenue ($m) by Segment, Historic, 2002-2009 128
Figure 67: Infectious Immunology, France, Revenue ($m) by Segment, Forecast, 2009-2016 130
Figure 68: Infectious Immunology, France, Company Share (%), 2009 133
Figure 69: Microbiology Culture, Market Segmentation 135
Figure 70: Microbiology Culture Market, France, Revenue Mix ($m), 2009 136
Figure 71: Microbiology Culture Market, France, Category Contribution (%), 2009 137
Figure 72: Microbiology Culture, France, Revenue ($m) by Segment, Historic, 2002-2009 138
Figure 73: Microbiology Culture, France, Revenue ($m) by Segment, Forecast, 2009-2016 140
Figure 74: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 142
Figure 75: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 144
Figure 76: Microbiology Culture, France, Company Share (%), 2009 147
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),France In Vitro Diagnostics Market, 2009 149
Figure 78: Siemens Healthcare, Company Share (%),France In Vitro Diagnostics Market, 2009 150
Figure 79: Abbott Laboratories, Company Share (%),France In Vitro Diagnostics Market, 2009 151
Figure 80: bioMerieux S.A., Company Share (%),France In Vitro Diagnostics Market, 2009 152
Figure 81: Beckman Coulter, Inc., Company Share (%),France In Vitro Diagnostics Market, 2009 153
Figure 82: Ortho-Clinical Diagnostics Inc., Company Share (%),France In Vitro Diagnostics Market, 2009 154
Figure 83: GlobalData Methodology 192
Companies mentionedF. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
bioMerieux S.A.
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Inverness Medical Innovations, Inc.
Becton, Dickinson and Company
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 8/11
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Bio-Rad Laboratories, Inc.
Hologic, Inc.
OLYMPUS CORPORATION
Mindray Medical International Limited
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB
Sysmex Europe GmbH
Argene S.A.
Biocode Hycel
EUROMEDEX
The Elitech Group
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 9/11
10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
France In Vitro Diagnostics Market Outlook to 2016
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 3 500.00 Quantity: _____
Site License--USD 7 000.00 Quantity: _____
Corporate License--USD 10 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 10/11
11. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 11/11